Dual inhibition of Ataxia-telangiectasia and Rad3-related (ATR) and Poly-ADP polymerase (PAPR) pathways enhances Topoisomerase l cytotoxicity in colon cancer cell lines:pre- clinical assessment of pathway-specific novel therapeutics
Manipulating the DNA repair mechanisms involved in the repair of Topoisomerase-I (Top I) mediated DNA damage may enhance the therapeutic benefits of Top I poisons. Poly-ADP ribose polymerase (PARP) inhibitors can increase the cytotoxicity of several anticancer agents by inhibiting various DNA repair...
Main Author: | Abu Sanad, Atlal |
---|---|
Other Authors: | Lawrence Panasci (Internal/Supervisor) |
Format: | Others |
Language: | en |
Published: |
McGill University
2014
|
Subjects: | |
Online Access: | http://digitool.Library.McGill.CA:80/R/?func=dbin-jump-full&object_id=123053 |
Similar Items
-
Exploration of Ataxia Telangiectasia and Rad3-Related’s (ATR’s) Role in Cell Death Regulation: Implications in Development, Cancer, and Stroke
by: Cartwright, Brian
Published: (2019) -
Targeting ataxia telangiectasia-mutated and Rad3-related kinase (ATR) in PTEN-deficient breast cancers for personalized cancer therapy
by: Alsubhi, Nouf
Published: (2018) -
Investigation of the role of poly(ADP-ribose)polymerase inhibition in topoisomerase I poison-induced cytotoxicity
by: Znojek, Pawel Jacek
Published: (2012) -
Ataxia telangiectasia mutated and Rad3 related (ATR) protein kinase inhibition is synthetically lethal in XRCC1 deficient ovarian cancer cells.
by: Rebeka Sultana, et al.
Published: (2013-01-01) -
Ataxia telangiectasia
by: Letícia Sauma, et al.
Published: (2015-07-01)